Stock screenerAll disclosures →
EDGAR →
WGRX
Conviction 67HealthcareScan · Thu, Jun 25, 2026WGRX$2.86+1.42%
ResistanceSupportVol 14Vol MA14 32.54K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price2.86
Change+1.42%
Gap+4.61%
Rel volume0.02×
Avg volume555.23K
Avg $ vol2.07M
SMA 203.66
SMA 501.67
SMA 2000.7938
Price vs 50+71.22%
Price vs 200+260.31%
MA stackbullish
50/200 cross—
Supertrendup · 2.61
RSI (14)50
MACD hist-0.24
MACD crossbear · 8d
Stoch %K / %D3 / 2
ADX (14)39
+DI / −DI25 / 24
RSI divergence—
MACD divergence—
ATR %+12.63%
ADR %10.89%
52w high4.39
52w low0.0788
From 52w high-34.85%
Above 52w low+3529.44%
New 52w highNo
SqueezeOff
Bollinger width49.17%
%B0.05
Donchian pos2.98%
Donchian high4.49
Donchian low2.81
AVWAP (52w high)3.80
vs AVWAP high-24.81%
AVWAP (52w low)0.1849
vs AVWAP low+1446.92%
OBV trendUp
Chaikin MF (20)-0.19
Today vs 20d0.02×
Avg vol (14d)32.54K
Avg vol (20d)555.23K
Avg $ vol (20d)2.07M
Market cap359.42M
RS 3m (vs SPY)+2310.42%
RS 6m (vs SPY)+472.87%
RS line new highNo
Trend template5/8
Technical rank80.1
1 week-22.70%
1 month-25.13%
3 months+2197.19%
6 months+512.03%
1 year+183.17%
YTD+559.75%
P/E-3.55
P/B-23.86
P/S15.40
P/FCF—
EPS-1.43
Div yield—
ROE672.36%
ROA-336.15%
Debt/Eq-1.26
Current0.09
EV/EBITDA-4.18
Gross margin-27.54%
Net margin-433.95%
Rev growth28.73%
EPS growth-1377.12%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value378.37M
Revenue1.56M
Net income-7.74M
Gross profit170.22K
Free cash flow—
IndustryWHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
ExchangeNasdaq
Shares out2.51M
Employees—
ListedFri, Feb 21, 2025
Free float55.92M
Float %46.5%
Short interest444.59K
Days to cover0.1d
Short volume45.9%
Squeeze score6 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction67 / 100
Pattern quality—
Tech rank80.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.37
Support0.0748
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in WGRX
No recent disclosed trades by Congress in WGRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in WGRX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
AJJARAPU SURENDRA K Director · Common Stock · 2026-06-22 | Exercise | 100K | $500 | 2026-06-22 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Warrant · 2026-06-22 | Exercise | 100K | — | 2026-06-22 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Common Stock · 2026-06-22 | Exercise | 100K | $500 | 2026-06-22 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Warrant · 2026-06-22 | Exercise | 100K | — | 2026-06-22 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Warrant · 2026-03-31 | Grant | 5M | $500 | 2026-03-31 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Common Stock · 2026-03-31 | Grant | 5M | $1.0M | 2026-03-31 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Warrant · 2026-03-31 | Grant | 5M | $500 | 2026-03-31 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Common Stock · 2026-03-31 | Grant | 5M | $1.0M | 2026-03-31 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Warrant · 2026-03-31 | Grant | 5M | $50K | 2026-03-31 | 2026-04-23 |
Patel Prashant Chief Executive Officer · Warrant · 2026-03-31 | Grant | 5M | $50K | 2026-03-31 | 2026-04-23 |
SEC filings
EDGAR filings in WGRX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.